Oral Pharmacotherapy for Male Sexual Dysfunction A Guide to Clinical Management (Current Clinical Urology) (Original PDF from Publisher)

1.1.Description

In the 1960s, a generation reached sexual maturity, and the introduction of the contraceptive pill, often simply referred to as the “pill,” symbolized a significant leap toward sexual freedom, sparking a sexual revolution. This innovation liberated women from the fear of unintended pregnancies and provided men with enhanced sexual opportunities.

However, in the realm of sexual medicine, a new era dawned that was detached from fertility concerns and solely focused on sexual enhancement. The year 1998 marked a pivotal moment with the introduction of the first prescription drug designed to address erectile dysfunction (ED) – sildenafil, commonly known as Viagra.

This drug reinvigorated aging male veterans of the sexual revolution, revolutionized sexual medicine, and transformed societal perceptions of aging and sexuality. These oral phosphodiesterase inhibitors (PDE-type 5) have proven highly effective in treating ED, creating greater awareness of this condition, its comorbidities, and its impact on the quality of life. Subsequently, two more PDE-type 5 inhibitors, tadalafil (Cialis) and vardenafil (Levitra), were approved for use, further shaping the landscape of sexual medicine.

Oral Pharmacotherapy for Male Sexual Dysfunction A Guide to Clinical Management (Current Clinical Urology) (Original PDF from Publisher)

1.2.Key Features

The key features of the book “Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” include:

1. Comprehensive Coverage: The book provides an in-depth and comprehensive exploration of oral pharmacotherapy for male sexual dysfunction, covering various aspects of this field.

2. Historical Context: It discusses the historical evolution of oral treatments for male sexual dysfunction, highlighting the transformative impact these drugs have had on sexual medicine.

3. Clinical Insights: “Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” offers valuable clinical insights and practical guidance for healthcare professionals in the field of sexual medicine.

4. Innovative Treatments: It covers not only the well-known sildenafil (Viagra) but also the newer oral PDE-type 5 inhibitors, tadalafil (Cialis) and vardenafil (Levitra), providing up-to-date information on these treatments.

5. Impact on Society: “Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” delves into the broader societal implications of these treatments, including changing attitudes among patients and their partners.

6. Quality of Life: “Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” emphasizes the effects of erectile dysfunction on the quality of life and the importance of addressing this condition effectively.

7. Clinical Management Guide: The book serves as a practical guide for clinical management in the field of male sexual dysfunction.

Overall, “Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” offers a comprehensive and informative resource for healthcare professionals, researchers, and anyone interested in understanding and managing male sexual dysfunction with a focus on oral pharmacotherapy.

Oral Pharmacotherapy for Male Sexual Dysfunction A Guide to Clinical Management (Current Clinical Urology) (Original PDF from Publisher)

1.3. About Writer

Dr. Gregory A. Broderick is a distinguished urologist known for his significant contributions to the field of sexual medicine and urology. He completed his medical education at the State University of New York Downstate Medical Center and later pursued his urology residency at the Tulane University School of Medicine. Dr. Broderick’s illustrious career has been marked by his pioneering work in the treatment of erectile dysfunction and male sexual dysfunction, particularly through oral pharmacotherapy.

He has been at the forefront of clinical research, focusing on innovative treatments and therapies for male sexual health. Dr. Broderick’s research and clinical expertise have significantly advanced the understanding and management of male sexual dysfunction, earning him recognition and respect within the medical community.

Throughout his career, he has published extensively, contributing to the scientific literature and sharing his knowledge with fellow healthcare professionals. Dr. Gregory A. Broderick’s achievements have had a profound impact on the field of sexual medicine and urology, ultimately improving the quality of life for patients dealing with these conditions.

Oral Pharmacotherapy for Male Sexual Dysfunction A Guide to Clinical Management (Current Clinical Urology) (Original PDF from Publisher)

Summary

“Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” delves into the revolution that oral phosphodiesterase inhibitors, including sildenafil (Viagra), have brought to the field of sexual medicine. Dr. Gregory A. Broderick, a prominent figure in urology, explores the profound impact of these medications on male sexual health.

“Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management (Current Clinical Urology)” covers the history, preclinical studies, and clinical application of these drugs, transforming the treatment of erectile dysfunction and related comorbidities. With insights into how these pharmacotherapies have shifted patient perspectives and practice patterns in sexual medicine, the book provides a comprehensive guide to the clinical management of male sexual dysfunction, ultimately enhancing patients’ quality of life and sexual well-being.